Nick A. Paras,James Brown,Yuan Cheng,Stephen A. Hitchcock,Ted Judd,Patricia Lopez,Ana Elena Minatti,Thomas Nixey,Timothy Powers,Christopher M. Tegley,Qiufen Xue,Bryant Yang,Wenge Zhong
申请号：
US13522823
公开号：
US20130040931A1
申请日:
2011.01.14
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimers disease (AD) and related conditions. In one embodiment, the compounds have a general Formula (I) wherein ring A, B1, B2, B3, L, R1, R2, ring Z, m and n of Formula I are defined herein. The invention also includes use of these compounds in pharmaceutical compositions for treatment, prophylactic or therapeutic, of disorders and conditions related to the activity of beta-secretase protein. Such disorders include, for example, Alzheimers Disease (AD), cognitive deficits, cognitive impairment, schizophrenia and other central nervous system conditions related to and/or caused by the formation and/or deposition of plaque on the brain. The invention also comprises further embodiments of Formula (I), intermediates and processes useful for the preparation of compounds of Formula (I).
